Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Anticarcinogenic Agents. Found 15 abstracts

Lubet RA, Clapper ML, McCormick DL, Pereira MA, Chang WC, Steele VE, Fischer SM, Juliana MM, Grubbs CJ. Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancers. Oncol Rep. 2012 May;27(5):1400-6.
Jordan VC. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point. Cancer Epidemiology, Biomarkers and Prevention. 2007 Nov;16(11):2207-9.
Jordan VC. Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Nature reviews Cancer. 2007 Jan;7(1):46-53.
Jordan VC. Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer. British journal of pharmacology. 2006 Jan;147 Suppl 1:S269-76.
Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Ozols RF, Daly MB, Klein-Szanto A, Hamilton TC, Bast RC, Brewer MA. Specific keynote: chemoprevention of ovarian cancer: the journey begins. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S59-66; discussion S67-70.
Lu S, Zhang X, Badawi AF, El-Sohemy A, Archer MC. Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids. Cancer letters. 2002 Oct 08;184(1):7-12.
Ruggeri BA, Robinson C, Angeles T, Wilkinson Jt, Clapper ML. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth. Clin Cancer Res. 2002 Jan;8(1):267-74.
Piazza GA, Thompson WJ, Pamukcu R, Alila HW, Whitehead CM, Liu L, Fetter JR, Gresh WE, Klein-Szanto AJ, Farnell DR, Eto I, Grubbs CJ. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis. Cancer Res. 2001 May 15;61(10):3961-8.
Szarka CE, Yao KS, Pfeiffer GR, Balshem AM, Litwin S, Frucht H, Goosenberg EB, Engstrom PF, Clapper ML, O'Dwyer PJ. Chronic dosing of oltipraz in people at increased risk for colorectal cancer. Cancer Detect Prev. 2001 Jan;25(4):352-61.
Baselli EC, Greenberg RE. Intravesical therapy for superficial bladder cancer. Oncology (Huntingt). 2000 May;14(5):719-29; discussion 729-31, 734, 737.
Russo IH, Russo J. Hormonal approach to breast cancer prevention. J Cell Biochem Suppl. 2000 Jan;34:1-6.
O'Dwyer PJ, Clayton M, Halbherr T, Myers CB, Yao K. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells. Clin Cancer Res. 1997 May;3(5):783-91.
O'Dwyer PJ, Johnson SW, Khater C, Krueger A, Matsumoto Y, Hamilton TC, Yao KS. The chemopreventive agent oltipraz stimulates repair of damaged DNA. Cancer Res. 1997 Mar 15;57(6):1050-3.
Wilkinson Jt, Clapper ML. Detoxication enzymes and chemoprevention. Proc Soc Exp Biol Med. 1997 Nov;216(2):192-200.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Anticarcinogenic Agents

Anticarcinogenic Agents prevention & control Female therapeutic use Human Rats Non-US Gov't Support metabolism drug effects genetics US Gov't Support-PHS pharmacology Pyrazines Breast Neoplasms Cultured Tumor Cells pathology drug therapy Animal Glutathione Transferase Sulfonamides Tamoxifen Male Cell Division Sprague-Dawley Rats Drug Dose-Response Relationship chemically induced Cell Cycle toxicity Experimental Mammary Neoplasms Bladder Neoplasms antagonists & inhibitors Cyclooxygenase Inhibitors Raloxifene Prostaglandin-Endoperoxide Synthase Methylnitrosourea Risk Factors biosynthesis analogs & derivatives Mice Isoenzymes Drug Metabolic Detoxication NAD(P)H Dehydrogenase (Quinone) Enzyme Induction Inbred F344 Rats methods administration & dosage Chemoprevention Colonic Neoplasms adverse effects Hormonal Antineoplastic Agents Carcinogens Apoptosis Neoplasms 21st Century History Antineoplastic Antibiotics Insulin-Like Growth Factor I ad [Administration & Dosage] Heterologous Transplantation Oral Contraceptives Colorectal Neoplasms Antineoplastic Agents Residual Neoplasm Pancreatic Ribonuclease EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) Ovarian Neoplasms Intestinal Neoplasms pd [Pharmacology] Neoplasm DNA 61-90-5 (Leucine) Cyclooxygenase 2 Inhibitors de [Drug Effects] Knockout Mice Tetrahydronaphthalenes pc [Prevention & Control] Receptor Protein-Tyrosine Kinases Chemical Models Interferons Estrogen Receptors antagonists & Antioxidants Cyclic GMP-Dependent Protein Kinases Immunologic Adjuvants Pyrazoles Estrogen Antagonists Thiotepa Angiogenesis Inhibitors Cytoplasmic and Nuclear) 0 (Receptors 0 (Carcinogens) Enzyme Activation enzymology Genetic Transcription ag [Agonists] physiology Fluorenes 5'-Cyclic-GMP Phosphodiesterase 3' inhibitors 169590-42-5 (celecoxib) Gene Expression Regulation Cyclic GMP 0 (Cyclooxygenase Inhibitors) Pathologic Neovascularization Middle Age Drug Synergism Enzymes Intravesical Administration Vascular Endothelium Unsaturated Fatty Acids 20th Century History 684-93-5 (Methylnitrosourea) blood Mycobacterium bovis 80 and over Aged Cisplatin Reproductive History Transitional Cell Carcinoma aa [Analogs & Derivatives] Postmenopause DNA Repair Glutathione Fibroblast Growth Factor Receptors Clinical Trials as Topic Oligonucleotide Array Sequence Analysis Fenretinide 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine) Unsaturated Dietary Fats Kinetics 0 (Fluorenes) ai [Antagonists & Inhibitors] Animal Disease Models Dinoprostone 0 (15-deoxyprostaglandin J2) Nude Mice Biological Models Hemangiosarcoma Liver prevention & Non-Steroidal Anti-Inflammatory Agents Inhibitory Concentration 50 physiopathology Fluorescence Microscopy Neoplastic Gene Expression Regulation Dietary Fats pharmacokinetics Hormones Doxorubicin Mitomycin Vascular Endothelial Growth Factor Receptors Biological Tumor Markers Animal Mammary Neoplasms Aged
Last updated on Monday, August 10, 2020